Labiotech.eu

cancer immunotherapy immunos therapeutics

News and Trends 11 Dec 2019

€14M Series A to Fund Cancer Immunotherapy Boosting Checkpoint Inhibitors

The Swiss biotech ImmunOs Therapeutics has raised a Series A round of €13.7M (CHF 15M) that will fund the first human trials of its cancer immunotherapy that could improve the response of cancer patients to checkpoint inhibitors. The round was co-led by the Swiss life sciences venture capital firm BioMedPartners and by Pfizer Ventures. The […]

December 11, 2019 - 2 minutesmins - By Jonathan Smith

Interview 11 Dec 2019

Collaboration Between Founders and Investors Primes Biotech Startups for Success

How can entrepreneurs work with investors to maximize the chances of their company succeeding? Venture capital partner Nanna Lüneborg and biotech entrepreneur Mai-Britt Zocca spoke at Labiotech Refresh in Copenhagen about their experiences in founding IO Biotech, a Danish biotech startup that develops cancer immunotherapies. Zocca and Lüneborg were both involved in setting up IO […]

December 11, 2019 - 5 minutesmins - By Jonathan Smith

Futura medical erectile dysfunction medication

More News! 10 Dec 2019

After Phase III Failure, UK Firm Pushes Placebo to Treat Erectile Dysfunction

The strong placebo effect seen in Futura Medical’s phase III trial in erectile dysfunction has not deterred the company, but has instead encouraged it to seek approval for its medical device delivering the placebo rather than the drug as originally intended. Based in Surrey, UK, Futura Medical is developing a medical device used […]

December 10, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

More News! 10 Dec 2019

ObsEva’s Oral Treatment for Uterine Fibroids Nails Phase III

An oral drug developed by the Swiss company ObsEva was shown to reduce menstrual bleeding and pain caused by uterine fibroids. The phase III trial tested ObsEva’s drug candidate linzagolix in 535 women suffering from heavy menstrual bleeding caused by benign tumors in the uterus called uterine fibroids. The effects of the drug were compared […]

December 10, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 9 Dec 2019

Autolus Reveals Early Clinical Data of Next-Gen CAR-T Therapy

London-based Autolus has shown its next-generation CAR T-cell therapy does not induce some of the severe side effects that have led to deaths in patients treated with CAR T-cell treatments currently on the market. Since their arrival on the market in 2017, CAR T-cell therapies have provided hope to patients with rare forms of blood […]

December 9, 2019 - 4 minutesmins - By Clara Rodríguez Fernández

dna data storage self replicating machine

News and Trends 9 Dec 2019

Scientists Use DNA Data Storage to Hide Information in Everyday Objects

Scientists have developed a method for storing DNA data in 3D-printed objects, which could one day allow machines to replicate themselves. The group, based at ETH Zurich, Switzerland, as well as in Israel and the US, began by synthesizing DNA molecules that encode blueprints of the Stanford bunny, a rabbit-shaped object commonly used in testing […]

December 9, 2019 - 4 minutesmins - By Jonathan Smith

In Depth 9 Dec 2019

As Big Pharma Abandons Neuroscience, Can Biotech Provide Answers?

With big pharma exiting the neurology space in droves, biotech innovation might be the key to bring about a much-needed shift. At the Bio-Europe conference in Hamburg last month, experts weighed in on the challenges and future of neuroscience. Over the last decade, big pharma has become disillusioned with neuroscience research. Eli Lilly, Amgen, Pfizer, […]

December 9, 2019 - 9 minutesmins - By Clara Rodríguez Fernández

colorectal cancer mologen cancer immunotherapy

News and Trends 6 Dec 2019

Update: Cancer Immunotherapy Biotech Files for Insolvency

Update (06/12/2019): Following the phase III failure of its immunotherapy drug for colorectal cancer in the summer, the German company Mologen has filed for insolvency. Published 06/08/2019 A DNA immunotherapy drug developed by the German company Mologen has failed to improve the survival of patients with colorectal cancer in a phase III trial. The phase […]

December 6, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 6 Dec 2019

Dutch Startup Gets €9M to Create First Lab-Grown Pork Prototype

Dutch startup Meatable has raised €9M in a seed round that will allow the company to host a tasting of its first prototype of lab-grown pork by summer 2020. The fundraising was led by the German VC BlueYard Capital, which had participated in Meatable’s previous €3M round last year. New investors include business angels Albert […]

December 6, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

acute heart failure 4teen4 pharmaceuticals

More News! 5 Dec 2019

German Biotech Raises €7M Series A to Treat Acute Heart Failure

4TEEN4 Pharmaceuticals has raised a Series A round of €6.9M to fuel the development of a first-in-class antibody drug that could reduce mortality in acute heart failure. The round was led by Brandenburg Kapital, a subsidiary of the German investment bank Investitionsbank des Landes Brandenburg. Other investors in the round, including business angels and private […]

December 5, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 4 Dec 2019

€48M Series B Fuels Immunotherapies for Cancer and Autoimmune Diseases

ImCheck Therapeutics has raised a Series B round worth €48M to fund the development of first-in-class immunotherapies that treat cancer and autoimmune diseases by targeting a rare type of immune cells called a gamma delta T-cell. ImCheck Therapeutics’ Series B round was led by Pfizer Ventures — the venture capital arm of the big pharma […]

December 4, 2019 - 3 minutesmins - By Jonathan Smith

Best in Biotech 3 Dec 2019

Industry Perspectives: Women in Biotech 2019

Women are underrepresented in biotech leadership roles in Europe, but things are slowly improving. We spoke to five senior women from the industry who told us their stories. At least half of life sciences and medical students across Europe are women. In the biotech and pharma industry, this statistic is similar in entry level jobs, […]

December 3, 2019 - 5 minutesmins - By Helen Albert

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

€14M Series A to Fund Cancer Immunotherapy Boosting Checkpoint Inhibitors

Collaboration Between Founders and Investors Primes Biotech Startups for Success

After Phase III Failure, UK Firm Pushes Placebo to Treat Erectile Dysfunction

ObsEva’s Oral Treatment for Uterine Fibroids Nails Phase III

Autolus Reveals Early Clinical Data of Next-Gen CAR-T Therapy

Scientists Use DNA Data Storage to Hide Information in Everyday Objects

As Big Pharma Abandons Neuroscience, Can Biotech Provide Answers?

Update: Cancer Immunotherapy Biotech Files for Insolvency

Dutch Startup Gets €9M to Create First Lab-Grown Pork Prototype

German Biotech Raises €7M Series A to Treat Acute Heart Failure

€48M Series B Fuels Immunotherapies for Cancer and Autoimmune Diseases

Industry Perspectives: Women in Biotech 2019

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!